This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: K David Mirfakhrae: Innovator in Stereoselective Reduction Processes
Introduction
K David Mirfakhrae is a notable inventor based in North Brunswick, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of stereoselective processes for the preparation of valuable chemical compounds. His work is particularly relevant in the context of medical applications, especially concerning Alzheimer's disease.
Latest Patents
K David Mirfakhrae holds a patent for the invention titled "Stereoselective reduction of substituted acetophenone." This patent describes novel stereoselective processes for the preparation of (S)-1-arylethanols through the reduction of keto group-containing compounds using microorganisms. The (S)-1-arylethanols produced are useful intermediates in the synthesis of compounds that inhibit γ-secretase, which is beneficial in the treatment of Alzheimer's disease. He has 1 patent to his name.
Career Highlights
Mirfakhrae is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development in innovative chemical processes that have the potential to impact therapeutic solutions.
Collaborations
Throughout his career, K David Mirfakhrae has collaborated with esteemed colleagues, including Ramesh N Patel and Animesh Goswami. These collaborations have fostered a productive environment for innovation and advancement in their respective fields.
Conclusion
K David Mirfakhrae's contributions to the field of stereoselective reduction processes highlight his commitment to advancing chemical research with significant implications for healthcare. His work continues to pave the way for new therapeutic solutions in the fight against Alzheimer's disease.